|
Synonyms: ACT-078 | Eloxatin®
oxaliplatin is an approved drug (FDA (2002))
Compound class:
Synthetic organic
Comment: Oxaliplatin is a platinum-based chemotherapy drug in the same class as carboplatin and cisplatin. Its main action is as a nucleic acid alkylating agent (see Clinical Data tab for further details). It is a platinum-chelating molecular complex (see CID 9887053).
|
Classification  |
|
| Compound class | Synthetic organic |
| Approved drug? | Yes (FDA (2002)) |
| WHO Essential Medicine | WHO Essential Medicines List (EML) (23rd List, 2023). Access PDF version. Click to view more information about the WHO Model Lists of Essential Medicines. |
| International Nonproprietary Names |
|
| INN number | INN |
| 6012 | oxaliplatin |
| Synonyms |
| ACT-078 | Eloxatin® |
| Database Links |
|
| CAS Registry No. | 63121-00-6 |
| ChEMBL Ligand | CHEMBL414804 |
| DrugBank Ligand | DB00526 |
| GtoPdb PubChem SID | 178104005 |
| Search PubMed clinical trials | oxaliplatin |
| Search PubMed titles | oxaliplatin |
| Search PubMed titles/abstracts | oxaliplatin |
| Wikipedia | Oxaliplatin |
